The areas of Chronic Lung Disease (Emphysema, Bronchitis and asthma) from a basic and applied research perspective, cardiopulmonary adaptations to exercise and health outcomes. His public health and business expertise has proven invaluable in assessing the impact of new technologies and emerging approaches to medical practice, as well as, assessing the costs-benefit outcomes.